Gokul Das, PhD of Roswell Park, Department of Pharmacology and Therapeutics gives an overview of his abstract, Novel effect of tamoxifen therapy: disruption of ER-p53 interaction leading to altered gene expression profile in human breast tumors, which was presented at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.